1042P Objective response rate as an intermediate surrogate endpoint to predict overall survival at 12 months
نویسندگان
چکیده
منابع مشابه
Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma
Alexander et al recently introduced a different interpretation involving our paper, in which we systematically evaluated glioblastoma clinical trials published from 1991 to the present and demonstrated that progression-free survival (PFS) may be an appropriate surrogate endpoint for overall survival (OS). Although the authors did not raise any methodological and clinical questions directly to u...
متن کاملProgression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials
BACKGROUND The aim of this study was to determine correlations between progression-free survival (PFS) and the objective response rate (ORR) with overall survival (OS) in glioblastoma and to evaluate their potential use as surrogates for OS. METHOD Published glioblastoma trials reporting OS and ORR and/or PFS with sufficient detail were included in correlative analyses using weighted linear r...
متن کاملResponse rate as an endpoint in clinical trials.
JNCI Vol. 99, Issue 2 | January 17, 2007 been changing somewhat in recent years for treatments without direct cytotoxic effects. In designing clinical trials in a specifi c disease that involve the assessment of objective response, several questions should be asked, and the existing evidence bearing on the answers to those questions should be assessed before deciding on how response rate as an ...
متن کاملAn Objective Surrogate for Presence: Physiological Response
This talk discusses our investigation into an objective presence measure. In our experiment, we investigated the correlation among a post-experiment presence questionnaire, human peripheral response (electrodermal activity and skin temperature), and a behavioral-presence questionnaire. Our findings show that the measures do correlate and have use as a potential objective surrogate for subjectiv...
متن کاملModified two‐dimensional response as surrogate marker of overall survival in patients with metastatic colorectal cancer
The identification of surrogate markers for long-term outcomes in patients with metastatic colorectal cancer (mCRC) may help in designing treatment regimens. The aim of this study was to assess whether two-dimensional response (2-DR) can serve as a new surrogate marker for overall survival (OS) in patients with mCRC. The study group consisted of 99 patients with mCRC from two independent cohort...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2020
ISSN: 0923-7534
DOI: 10.1016/j.annonc.2020.08.1162